Back to Article

Differential Complete Blood Count for Diagnosis of COVID-19?

World Journal of Medical Microbiology | Vol 2, Issue 1

Table 4. Comparison oflaboratory investigations between case and control groups.

VariableCase GroupControl GroupTotalX2 ValueP Value (Sig)
LeucopeniaPositive21 (24.1%)4 (4.7%)25 (14.5%)13.2840.000
(VHS)
Negative66 (75.9%)82 (95.3%)148 (85.5%)
NeutropeniaPositive12 (13.8%)5 (5.8%)17 (9.8%)3.1070.078
(NS)
Negative75 (86.2%)81 (94.2%)156 (90.2%)
LymphopeniaPositive53 (60.9%)21 (24.4%)74 (42.8%)23.5400.000
(VHS)
Negative34 (39.1%)65 (75.6%)99 (57.2%)
EosinocytopeniaPositive35 (40.2%)25 (29.1%)60 (34.7%)2.3780.123
(NS)
Negative52 (59.8%)61 (70.9%)113 (65.3%)
MonocytosisPositive2 (2.3%)14 (16.3%)16 (9.2%)10.0710.002 (HS)
Negative85 (97.7%)72 (83.7%)157 (90.8%)
High CRPPositive64 (73.6%)58 (67.4%)122 (70.5%)0.7800.377
(NS)
Negative 23 (26.4%)28 (32.6%)51 (29.5%)
Serum FerritinPositive44 (50.6%)11 (12.8%)55 (31.8%)28.4730.001
(VHS)
Negative43 (49.4%)75 (87.2%)118 (68.2%)
High ALT Positive25 (28.7%)7 (8.1%)32 (18.5%)12.1690.000
(VHS)
Negative62 (71.3%)79 (91.9%)141 (81.5%)
High AST Positive20 (23.0%)5 (5.8%)25 (14.5%)10.3190.001
(VHS)
Negative67 (77.0%)81 (94.2%)148 (85.5%)

VHS: Very highly Significant NS: Non-Significant HS: Highly Significant.